Agilent Technologies, Inc. (0HAV.L)

USD 136.25

(-0.67%)

Long Term Debt Summary of Agilent Technologies, Inc.

  • Agilent Technologies, Inc.'s latest annual long term debt in 2023 was 2.73 Billion USD , up 0.07% from previous year.
  • Agilent Technologies, Inc.'s latest quarterly long term debt in 2024 Q2 was 2.13 Billion USD , down -16.4% from previous quarter.
  • Agilent Technologies, Inc. reported annual long term debt of 2.73 Billion USD in 2022, up 0.15% from previous year.
  • Agilent Technologies, Inc. reported annual long term debt of 2.72 Billion USD in 2021, up 19.48% from previous year.
  • Agilent Technologies, Inc. reported quarterly long term debt of 2.55 Billion USD for 2024 Q1, down -6.58% from previous quarter.
  • Agilent Technologies, Inc. reported quarterly long term debt of 2.13 Billion USD for 2024 Q3, up 0.05% from previous quarter.

Annual Long Term Debt Chart of Agilent Technologies, Inc. (2023 - 1998)

Historical Annual Long Term Debt of Agilent Technologies, Inc. (2023 - 1998)

Year Long Term Debt Long Term Debt Growth
2023 2.73 Billion USD 0.07%
2022 2.73 Billion USD 0.15%
2021 2.72 Billion USD 19.48%
2020 2.28 Billion USD 27.53%
2019 1.79 Billion USD -0.44%
2018 1.79 Billion USD -0.11%
2017 1.8 Billion USD -5.81%
2016 1.91 Billion USD 15.53%
2015 1.65 Billion USD -40.08%
2014 2.76 Billion USD 2.33%
2013 2.69 Billion USD 27.79%
2012 2.11 Billion USD 9.32%
2011 1.93 Billion USD -11.78%
2010 2.19 Billion USD -24.59%
2009 2.9 Billion USD 36.66%
2008 2.12 Billion USD 1.82%
2007 2.08 Billion USD 39.13%
2006 1.5 Billion USD 0.0%
2005 - USD -100.0%
2004 1.15 Billion USD 0.0%
2003 1.15 Billion USD 0.0%
2002 1.15 Billion USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%

Peer Long Term Debt Comparison of Agilent Technologies, Inc.

Name Long Term Debt Long Term Debt Difference
Editas Medicine, Inc. 24.37 Million USD -11121.894%
Dynavax Technologies Corporation 252.41 Million USD -983.52%
Supernus Pharmaceuticals, Inc. 33.19 Million USD -8138.944%
Perrigo Company plc 3.63 Billion USD 24.714%
Illumina, Inc. 1.48 Billion USD -83.68%
Thermo Fisher Scientific Inc. 31.3 Billion USD 91.264%
Iovance Biotherapeutics, Inc. 1 Million USD -273400.0%
Walgreens Boots Alliance, Inc. 8.04 Billion USD 66.0%
IQVIA Holdings Inc. 12.95 Billion USD 78.888%
Heron Therapeutics, Inc. 173.75 Million USD -1474.074%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD -1.188%
Unity Biotechnology, Inc. 23.53 Million USD -11519.015%
Waters Corporation 2.3 Billion USD -18.629%
Biogen Inc. 7.18 Billion USD 61.952%
Sangamo Therapeutics, Inc. 33.51 Million USD -8060.525%
Evolus, Inc. 120.35 Million USD -2172.368%
Adicet Bio, Inc. 17.7 Million USD -15349.359%
Cara Therapeutics, Inc. 37.07 Million USD -7276.143%
bluebird bio, Inc. 224.41 Million USD -1118.703%
Esperion Therapeutics, Inc. 501.54 Million USD -445.314%
FibroGen, Inc. 89.69 Million USD -2949.154%
Corbus Pharmaceuticals Holdings, Inc. 3.23 Million USD -84349.263%
Homology Medicines, Inc. 43.17 Million USD -6234.538%
Geron Corporation 35.05 Million USD -7702.916%
Alnylam Pharmaceuticals, Inc. 2.34 Billion USD -16.729%
Amicus Therapeutics, Inc. 387.85 Million USD -605.155%
Myriad Genetics, Inc. 130.9 Million USD -1989.381%
Viking Therapeutics, Inc. 936 Thousand USD -292100.855%
Intellia Therapeutics, Inc. 96.74 Million USD -2726.961%
Zoetis Inc. 6.56 Billion USD 58.333%
Abeona Therapeutics Inc. 4.4 Million USD -62030.85%
Mettler-Toledo International Inc. 1.97 Billion USD -38.442%
BioMarin Pharmaceutical Inc. 593.09 Million USD -361.14%
Vertex Pharmaceuticals Incorporated 724.7 Million USD -277.398%
Kala Pharmaceuticals, Inc. 34.19 Million USD -7899.415%
Ionis Pharmaceuticals, Inc. 1.4 Billion USD -95.305%
Atara Biotherapeutics, Inc. 45.69 Million USD -5885.6%
Verastem, Inc. 40.08 Million USD -6722.831%
Nektar Therapeutics 112.62 Million USD -2328.413%
Axsome Therapeutics, Inc. 178.07 Million USD -1435.913%
Aclaris Therapeutics, Inc. 3.07 Million USD -88872.023%
Sarepta Therapeutics, Inc. 1.13 Billion USD -141.498%
OPKO Health, Inc. 222.03 Million USD -1131.793%
Exelixis, Inc. 189.94 Million USD -1339.898%
Neurocrine Biosciences, Inc. 258.3 Million USD -958.846%
Corcept Therapeutics Incorporated - USD -Infinity%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 130.06 Million USD -2002.795%
Imunon, Inc. 1.13 Million USD -239961.161%
Blueprint Medicines Corporation 610.96 Million USD -347.655%
Insmed Incorporated 1.19 Billion USD -129.186%
Halozyme Therapeutics, Inc. 1.49 Billion USD -82.425%
Agios Pharmaceuticals, Inc. 56.98 Million USD -4699.256%
TG Therapeutics, Inc. 100.11 Million USD -2631.777%
Incyte Corporation 29.16 Million USD -9278.643%
Emergent BioSolutions Inc. 446.5 Million USD -512.542%